research

Bristol-Myers Squibb
Biotech

Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’

By Adam Feuerstein

beakers
First Opinion

The EPA’s proposed ‘transparency rule’ will harm health, safety, and the environment

By Lenny Teytelman, William Gunn, and Joanne Kamens

Cell-cial network
First Opinion

Creating a Facebook for cell communication can help treat disease

By Virginia Savova

Play
The Readout LOUD

Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Blood samples in lab
In the Lab

Scientists develop a ‘clock’ that can measure biological age based on blood proteins

By Andrew Joseph

Newborn bili lights
Health

How police shootings of unarmed black Americans could be harming the health of black infants

By Shraddha Chakradhar

Rep. Diana DeGette
Politics

Congress is hoping for another major medical research bill. But pharma’s not nearly as excited as before

By Nicholas Florko

Lake swimmer
In the Lab

Warning: Swimming and deep brain stimulation do not mix

By Elizabeth Cooney

Ebola treatment center in Beni
Health

Two Ebola treatments yield ‘substantial decrease’ in mortality, landmark trial shows

By Helen Branswell

HIV-1
In the Lab

For babies born with HIV, start treatment right away, study says

By Associated Press

Glass of beer
Health

With the help of ketamine, researchers rewrite memories in a bid to curb harmful drinking

By Megan Thielking

HIV test woman
First Opinion

Barring cisgender women from the Descovy trials was a bad call

By Oni Blackstock

Human T cells showing nuclei
Business

Facing bottlenecks in manufacturing cell therapies, Boston leaders plan to build their own

By Sharon Begley

Charles L. Sawyers
Health

Longtime cancer researcher Charles Sawyers named first STAT Biomedical Innovation Award winner

By Shraddha Chakradhar

I'm not a robot GIF
First Opinion

Bots started sabotaging my online research. I fought back

By Melissa Simone

Bernie Sanders, Sen. Elizabeth Warren
Politics

Warren and Sanders: More scrutiny needed of commercial boards that decide whether to green-light clinical trials

By Rebecca Robbins

Pharmalot

Pharmalittle: VCs warn Congress on drug-pricing bill; drugs look better than surgery or stents

By Elizabeth Cooney

Data sharing
First Opinion

Sharing clinical trial data: lessons from the YODA Project

By Joseph S. Ross, Joanne Waldstreicher, and Harlan M. Krumholz

non-emergency angioplasty
Health

Big study casts doubt on need for many heart procedures

By Associated Press

Exercise in space
In the Lab

Exercise helps astronauts cope with side effects of spaceflight. Could it help cancer patients too?

By Shraddha Chakradhar

Pups for science
Health

Old dogs, new tricks: 10,000 pets needed for canine aging study

By Associated Press

NIH
Health

More trial results are being posted to public database, but data quality is lacking, report finds

By Shraddha Chakradhar

Lipitor tablets
Health

Cholesterol levels dropping in U.S., but many still need care

By Associated Press

US soldiers
First Opinion

Diabetic foot ulcers: a silent killer of veterans

By David G. Armstrong

Alzheimer's risk
In the Lab

Long-neglected gene plays a bigger role in Alzheimer’s than suspected, study shows

By Sharon Begley

Research for trans teens
Health

Mental health studies lump transgender teens under one umbrella — and miss clues to help them in the process

By Megan Thielking

Digital health monitor
First Opinion

Digital endpoints library can aid clinical trials for new medicines

By Jen Goldsack, Rachel A. Chasse, and William A. Wood

CRISPR-CAS9 illustration
Health

First use of CRISPR against cancer in patients clears early safety hurdles

By Associated Press

David Liu- Broad Retreat
In the Lab

You had questions for David Liu about CRISPR, prime editing, and advice to young scientists. He has answers

By Sharon Begley

Your daily dose of news in health and medicine

Privacy Policy